DOCSLIB.ORG

A Thymus-Specific Member of the HMG Protein Family Regulates the Human T Cell Receptor Enhancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Thymus-Specific Member of the HMG Protein Family Regulates the Human T Cell Receptor Enhancer Downloaded from genesdev.cshlp.org on October 9, 2021 - Published by Cold Spring Harbor Laboratory Press A thymus-specific member of the HMG protein family regulates the human T cell receptor enhancer Marian L. Waterman, Wolfgang H. Fischer, 1 and Katherine A. Jones 2 Molecular Biology and Virology Laboratory and Regulatory Biology Laboratory, 1peptide Biology Laboratory, The Salk Institute, La Jolla, California 92037 USA The human T cell-specific transcription factor TCF-la plays a key role in the tissue-specific activation of the T cell receptor (TCR) Ca enhancer and binds to pyrimidine-rich elements (5'-PyCTTTG-3') present in a variety of other T cell-specific control regions. Using amino acid sequence information derived from the DNA affinity-purified protein, we have now isolated cDNA clones encoding TCF-la. The TCF-Ia cDNA contains a single 68-amino-acid domain that is homologous to a region conserved among high-mobility group (HMG) and nonhistone chromosomal proteins. Expression of full-length and mutant cDNA clones in bacteria reveal that the single HMG motif, which is predicted to contain two extended a-helical segments, is sufficient to direct the sequence-specific binding of TCF-lc~ to DNA. Northern blot experiments demonstrate further that TCF-I,~ mRNA is highly tissue specific, found primarily in the thymus or T cell lines. The immature CEM T cell line expresses relatively low levels of TCF-la mRNA, which are increased upon activation of these cells by phorbol esters. Interestingly, the cloned TCF-I¢~ protein is a potent transcriptional activator of the human TCRa enhancer in nonlymphoid cell lines, whereas the activity of the endogenous protein in T cell lines is strongly dependent on an additional T cell-specific protein that interacts with the core enhancer. TCF-let is currently unique among the newly emerging family of DNA-binding regulatory proteins that share the HMG motif in that it is a highly tissue-specific RNA polymerase II transcription factor. [Key Words: TCRa enhancer~ HMG protein~ T cell-specific transcription factor] Received January 2, 1991~ revised version accepted January 25, 1991. The development of pluripotent stem cells into highly with transcriptional regulation mediated by potent T specialized T cell lymphocytes can be defined by the cell-specific enhancers that have been mapped down- appearance and assembly at the cell surface of multicom- stream of many of these genes {Krimperdort et al. 1988~ ponent complexes containing the T cell receptor {TCR) McDougall et al. 1988~ Ho et al. 1989~ Winoto and Bal- and CD3 antigens. Functionally distinct T cell lineages timore 1989a~ Redondo et al. 1990}. bear either the et/B or ~//~ heterodimeric forms of the T The best-characterized of the TCR enhancers lies 4.5 cell receptor [Davis and Bjorkman 1988). TCR~t/B + cells kb downstream of the cx-chain gene (Chien et al. 1987} predominate in mature peripheral blood T cells {includ- and is recognized by a complex array of DNA-binding ing helper and cytotoxic cell subtypes) and function to proteins, although a minimal core segment spanning 100 mediate major histocompatability complex {MHC)- bp is sufficient for high-level activity in mature ot/B + T restricted antigen recognition in combination with ei- cell lines {Ho et al. 1989~ Winoto and Baltimore 1989a). ther the CD4 or CD8 antigens {for review, see Marrack This core segment interacts with three DNA-binding and Kappler 1987; Strominger 1989}. The TCR genes, proteins: a ubiquitously distributed member of the like other members of the immunoglobulin gene super- cAMP-responsive {CREB/ATF} transcription factor fam- family, are rearranged and expressed developmentally in ily (Ho et al. 1989), the T cell-specific TCF-lcx factor a stage-specific manner that begins with the ~//~-chain {Waterman and Jones 19901, and a distinct T cell-specific genes and follows with the B-chain and lastly the (x-chain protein (TCF-2~t} that may be a member of the c-ets pro- genes {Furley et al. 1986; Pardoll et al. 1987; Havran and tein family (Ho et al. 19901. The core TCRct enhancer is Allison 1988). The coordinate synthesis of the members a potent T cell-specific control region that can activate of the TCR-CD3 complex is accomplished by a combi- heterologous promoters in mature T cell lines, and each nation of both transcriptional and post-transcriptional of the three protein-binding sites is necessary for en- steps {Wilkinson and MacLeod 1988; Paillard et al. 1990}, hancer activity in vivo (Winoto and Baltimore 1989a~ Ho et al. 1990; Waterman and ]ones 19901. Interestingly, a 2Corresponding author. subfragment of the enhancer lacking the CRE motif re- 656 GENES & DEVELOPMENT 5:656-669 © 1991 by Cold Spring Harbor Laboratory ISSN 0890-9369/91 $3.00 Downloaded from genesdev.cshlp.org on October 9, 2021 - Published by Cold Spring Harbor Laboratory Press T cell-specific HMG transcription factor presses transcription from heterologous promoters in a T TCF-lu transcription factor was found to harbor a single cell-specific manner (Ho and Leiden 1990). The a en- 68-amino-acid domain that is homologous to a con- hancer is less active in immature T cell lines (e.g., served region of the high-mobility group (HMG) and CCRF-CEM cells) but can be stimulated in these cells by other nonhistone chromosomal proteins. This HMG mo- treatment with phorbol esters (Winoto and Baltimore tif is shown to be both necessary and sufficient for spe- 1989a), which also induces surface expression of the cific binding of TCF ol u to its conserved pyrimidine-rich TCRu/B complex (Shackelford et al. 1987). DNA element. The cloned TCF-lc, protein can also Rearrangement and expression of the TCRu gene is strongly activate the expression of a minimal promoter regulated in a lineage-specific manner in developing thy- linked to the TCRc~ enhancer in nonlymphoid cells. Ex- mocytes because the a-chain gene is transcribed in pression of TCF-lu mRNA is highly restricted to the TCRa/[3 + but not in TCR~//8 + T cells (for review, see thymus and to T cell lines and can be further induced Alt et al. 1987). In the mouse, the minimal 116- bp TCRu upon activation of an immature T cell line. These data enhancer core was found to be fully active in ~//8+ cell establish that TCF-lu belongs to a new family of regu- lines, whereas larger fragments of the enhancer (5 kb or latory proteins related by the shared HMG box homol- greater) were inactive (Winoto and Baltimore 1989b). ogy. Other members of this family include hUBF, a ubiq- These larger fragments contain multiple "silencer" ele- uitous RNA polymerase I enhancer-binding protein ments reported to extinguish enhancer activity in a va- (Jantzen et al. 1990), and SRY, a testis-specific protein riety of non-~f~ + cell lines. Consequently, the T cell- encoded on the Y chromosome that is implicated genet- specific factors associated with the minimal enhancer ically in human sex determination (Gubbay et al. 1990; appear to be expressed and active in both T cell subtypes Sinclair et al. 1990). TCF-lu is presently unique among but are subject to lineage-specific repression in ~/8 + T this family in that its specific DNA-binding activity is cells. determined by a single HMG motif, and it is required for We recently reported the purification and character- the T cell-specific regulation of RNA polymerase II ization of TCF-lu, a new T cell-specific DNA-binding genes. protein that recognizes the 100-bp core region of the hu- man TCRu enhancer (Waterman and Jones 1990). TCF-1~ was purified from nuclear extracts of Jurkat cells Results and shown to consist of a family of 57- to 53-kD proteins Amino acid sequence analysis of DNA that bind specifically to pyrimidine-rich elements (e.g., affinity-purified TCF-1 a 5'-PyCTTTG-3'), which are present in a variety of T cell- specific control regions, including the TCR~ enhancer, Our previous analysis of the T cell-specific TCF-lc~ fac- the p561ok and CD3 (~/and 8) promoters, and the HIV-1 tor indicated that it was a unique protein that had not long terminal repeat (LTR). More recently, we have been implicated previously in T cell-specific transcrip- found that the TGF-lu protein also interacts with the tional regulation (Waterman and Jones 1990). To isolate TCR8 enhancer (M.L. Waterman and K. Jones, unpubl.), cDNAs encoding TCF-lu and further characterize this as well as with transcriptional regulatory regions of the regulatory protein, -200 pmoles (16 ~g) of TCF-lu was murine CD4 gene (M.L. Waterman, K. Jones, J. Siu, and purified from Jurkat nuclear extracts, using a combina- S. Hedrick, unpubl.). A double point mutation within the tion of conventional gradient and DNA affinity chromo- TCRu enhancer (5'-PyCTTTG-3' to 5'-PyCATAG-3') tography. TCF-lu activity derives from a family of 57- to that eliminates the binding of affinity-purified TCF-lu 53-kD proteins, each of which is capable of binding DNA was found to decrease TCRa enhancer activity specifically in Southwestern blotting as well as gel exci- -100-fold in vivo (Waterman and Jones 1990). This mu- sion and renaturation experiments (Waterman and Jones tation also destroyed the striking synergism observed be- 1990). Three distinct TCF-lu proteins copurified with a tween tandem copies of the TCRR enhancer, effectively nonspecific DNA-binding protein of 116 kD during the eliminating T cell-specific transcriptional activity in purification procedure. The proteins were resolved on a vivo, and reduced enhancer activity in an in vitro tran- preparative denaturing SDS-polyacrylamide gel, trans- scription system derived from Jurkat nuclei.
Load more

Recommended publications
  • Deciphering the Functions of Ets2, Pten and P53 in Stromal Fibroblasts in Multiple
    Deciphering the Functions of Ets2, Pten and p53 in Stromal Fibroblasts in Multiple Breast Cancer Models DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Julie Wallace Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2013 Dissertation Committee: Michael C. Ostrowski, PhD, Advisor Gustavo Leone, PhD Denis Guttridge, PhD Dawn Chandler, PhD Copyright by Julie Wallace 2013 Abstract Breast cancer is the second most common cancer in American women, and is also the second leading cause of cancer death in women. It is estimated that nearly a quarter of a million new cases of invasive breast cancer will be diagnosed in women in the United States this year, and approximately 40,000 of these women will die from breast cancer. Although death rates have been on the decline for the past decade, there is still much we need to learn about this disease to improve prevention, detection and treatment strategies. The majority of early studies have focused on the malignant tumor cells themselves, and much has been learned concerning mutations, amplifications and other genetic and epigenetic alterations of these cells. However more recent work has acknowledged the strong influence of tumor stroma on the initiation, progression and recurrence of cancer. Under normal conditions this stroma has been shown to have protective effects against tumorigenesis, however the transformation of tumor cells manipulates this surrounding environment to actually promote malignancy. Fibroblasts in particular make up a significant portion of this stroma, and have been shown to impact various aspects of tumor cell biology.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,109,232 B2 Schwartz Et Al
    US009 109232B2 (12) United States Patent (10) Patent No.: US 9,109,232 B2 Schwartz et al. (45) Date of Patent: Aug. 18, 2015 (54) ETS2 AND MESP1 GENERATE CARDIAC Islas et al., Transcription factors ETS2 and MESP1 transdifferentiate PROGENITORS FROM FIBROBLASTS human dermal fibroblasts into cardiac progenitors; PNAS, Published online before print Jul. 23, 2012, doi: 10.1073/pnas. 11202991.09, 2012.* (71) Applicants: University of Houston, Houston, TX Melotti et al., Ets-2 and c-Myb Act Independently in Regulating (US); Texas Heart Institute, Houston, Expression of the Hematopoietic StemCell Antigen CD34:JBC, vol. TX (US); The Texas A&M University 269, No. 41, pp. 25303-25309, 1994.* System, College Station, TX (US) Takahashi et al., Induction of pluripotent stem cells from adulthuman fibroblasts by defined factors; Cell, vol. 131, pp. 861-872, 2007.* Naldini et al. In vivo gene delivery and stable transduction of (72) Inventors: Robert J. Schwartz, Houston, TX (US); nondividing cells by a lentiviral vector; Science, vol. 272, pp. 263 Vladimir N. Potaman, Houston, TX 267, 1996.* (US); Jose Francisco Islas, Houston, TX European Patent Office; Office Action; European Application No. (US) 117114082; Jul 22, 2013. European Patent Office; Response to Office Action; European Appli (73) Assignees: University of Houston, Houston, TX cation No. 11711408.2; Aug. 30, 2013. Chinese Patent Office; Office Action; Chinese Patent Application No. (US); Texas Heart Institute, Houston, 2011800 19561.0; Sep. 18, 2013. TX (US); The Texas A&M University Chinese Patent Office; Office Action (English translation); Chinese System, College Station, TX (US) Patent Application No. 2011800 19561.0; Sep.
    [Show full text]
  • Supplementary Data
    SUPPLEMENTARY DATA A cyclin D1-dependent transcriptional program predicts clinical outcome in mantle cell lymphoma Santiago Demajo et al. 1 SUPPLEMENTARY DATA INDEX Supplementary Methods p. 3 Supplementary References p. 8 Supplementary Tables (S1 to S5) p. 9 Supplementary Figures (S1 to S15) p. 17 2 SUPPLEMENTARY METHODS Western blot, immunoprecipitation, and qRT-PCR Western blot (WB) analysis was performed as previously described (1), using cyclin D1 (Santa Cruz Biotechnology, sc-753, RRID:AB_2070433) and tubulin (Sigma-Aldrich, T5168, RRID:AB_477579) antibodies. Co-immunoprecipitation assays were performed as described before (2), using cyclin D1 antibody (Santa Cruz Biotechnology, sc-8396, RRID:AB_627344) or control IgG (Santa Cruz Biotechnology, sc-2025, RRID:AB_737182) followed by protein G- magnetic beads (Invitrogen) incubation and elution with Glycine 100mM pH=2.5. Co-IP experiments were performed within five weeks after cell thawing. Cyclin D1 (Santa Cruz Biotechnology, sc-753), E2F4 (Bethyl, A302-134A, RRID:AB_1720353), FOXM1 (Santa Cruz Biotechnology, sc-502, RRID:AB_631523), and CBP (Santa Cruz Biotechnology, sc-7300, RRID:AB_626817) antibodies were used for WB detection. In figure 1A and supplementary figure S2A, the same blot was probed with cyclin D1 and tubulin antibodies by cutting the membrane. In figure 2H, cyclin D1 and CBP blots correspond to the same membrane while E2F4 and FOXM1 blots correspond to an independent membrane. Image acquisition was performed with ImageQuant LAS 4000 mini (GE Healthcare). Image processing and quantification were performed with Multi Gauge software (Fujifilm). For qRT-PCR analysis, cDNA was generated from 1 µg RNA with qScript cDNA Synthesis kit (Quantabio). qRT–PCR reaction was performed using SYBR green (Roche).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0068395 A1 Wood Et Al
    US 2006.0068395A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0068395 A1 Wood et al. (43) Pub. Date: Mar. 30, 2006 (54) SYNTHETIC NUCLEIC ACID MOLECULE (21) Appl. No.: 10/943,508 COMPOSITIONS AND METHODS OF PREPARATION (22) Filed: Sep. 17, 2004 (76) Inventors: Keith V. Wood, Mt. Horeb, WI (US); Publication Classification Monika G. Wood, Mt. Horeb, WI (US); Brian Almond, Fitchburg, WI (51) Int. Cl. (US); Aileen Paguio, Madison, WI CI2O I/68 (2006.01) (US); Frank Fan, Madison, WI (US) C7H 2L/04 (2006.01) (52) U.S. Cl. ........................... 435/6: 435/320.1; 536/23.1 Correspondence Address: SCHWEGMAN, LUNDBERG, WOESSNER & (57) ABSTRACT KLUTH 1600 TCF TOWER A method to prepare synthetic nucleic acid molecules having 121 SOUTHEIGHT STREET reduced inappropriate or unintended transcriptional charac MINNEAPOLIS, MN 55402 (US) teristics when expressed in a particular host cell. Patent Application Publication Mar. 30, 2006 Sheet 1 of 2 US 2006/0068395 A1 Figure 1 Amino Acid Codon Phe UUU, UUC Ser UCU, UCC, UCA, UCG, AGU, AGC Tyr UAU, UAC Cys UGU, UGC Leu UUA, UUG, CUU, CUC, CUA, CUG Trp UGG Pro CCU, CCC, CCA, CCG His CAU, CAC Arg CGU, CGC, CGA, CGG, AGA, AGG Gln CAA, CAG Ile AUU, AUC, AUA Thr ACU, ACC, ACA, ACG ASn AAU, AAC LyS AAA, AAG Met AUG Val GUU, GUC, GUA, GUG Ala GCU, GCC, GCA, GCG Asp GAU, GAC Gly GGU, GGC, GGA, GGG Glu GAA, GAG Patent Application Publication Mar. 30, 2006 Sheet 2 of 2 US 2006/0068395 A1 Spd Sequence pGL4B-4NN3.
    [Show full text]
  • Id3 Induces an Elk-1- and Caspase-8-Dependent Apoptotic Pathway In
    ID3 INDUCES AN ELK-1- AND CASPASE-8-DEPENDENT APOPTOTIC PATHWAY IN SQUAMOUS CARCINOMA CELLS A Dissertation submitted to the Faculty of the Graduate School of Arts and Sciences of Georgetown University in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biochemistry and Molecular & Cellular Biology By You-shin Chen, M.S. Washington, DC November 18, 2014 Copyright 2014 by You-shin Chen All Rights Reserved ii ID3 INDUCES AN ELK-1- AND CASPASE-8-DEPENDENT APOPTOTIC PATHWAY IN SQUAMOUS CARCINOMA CELLS You-shin Chen, M.S. Thesis Advisor: Dean S. Rosenthal, Ph.D. ABSTRACT Inhibitors of differentiation/DNA binding (Id) proteins are helix-loop-helix (HLH) transcription factors. The Id protein family (Id1-Id4) mediates tissue homeostasis by regulating cellular processes including differentiation, proliferation, and apoptosis. Previously, we found that Id3 induced apoptosis in immortalized human keratinocytes (Simbulan-Rosenthal et al., 2006), consistent with its role as a tumor suppressor (Richter et al., 2012; Schmitz et al., 2012). To investigate the role of Id3 in malignant SCC cells (A431), a tetracycline-regulated inducible system was used to induce Id3 in cell culture and mouse xenograft models. We found that upon Id3 induction, there was a decrease in cell number under low serum conditions, as well as in soft agar. Microarray, RT-PCR, immunoblot, siRNA, and inhibitor studies revealed that Id3 induced expression of Elk-1, an ETS-domain transcription factor, inducing procaspase-8 expression and activation. Id3 deletion mutants revealed that 80 C-terminal amino acids, including the HLH, are important for Id3-induced apoptosis.
    [Show full text]
  • Blood Vessel Control of Macrophage Maturation Promotes Arteriogenesis in Ischemia
    ARTICLE DOI: 10.1038/s41467-017-00953-2 OPEN Blood vessel control of macrophage maturation promotes arteriogenesis in ischemia Kashyap Krishnasamy1,2, Anne Limbourg1,3,10, Tamar Kapanadze1,2,3, Jaba Gamrekelashvili 1,2, Christian Beger1,2,3, Christine Häger1,11, Vladimir J. Lozanovski1,12, Christine S. Falk3,4, L. Christian Napp 1,5, Johann Bauersachs5, Matthias Mack6, Hermann Haller2, Christian Weber7,8, Ralf H. Adams 9 & Florian P. Limbourg 1,2 Ischemia causes an inflammatory response that is intended to restore perfusion and homeostasis yet often aggravates damage. Here we show, using conditional genetic deletion strategies together with adoptive cell transfer experiments in a mouse model of hind limb ischemia, that blood vessels control macrophage differentiation and maturation from recruited monocytes via Notch signaling, which in turn promotes arteriogenesis and tissue repair. Macrophage maturation is controlled by Notch ligand Dll1 expressed in vascular endothelial cells of arteries and requires macrophage canonical Notch signaling via Rbpj, which simultaneously suppresses an inflammatory macrophage fate. Conversely, conditional mutant mice lacking Dll1 or Rbpj show proliferation and transient accumulation of inflammatory macrophages, which antagonizes arteriogenesis and tissue repair. Furthermore, the effects of Notch are sufficient to generate mature macrophages from monocytes ex vivo that display a stable anti-inflammatory phenotype when challenged with pro-inflammatory stimuli. Thus, angiocrine Notch signaling fosters macrophage maturation during ischemia. 1 Vascular Medicine Research, Hannover Medical School, Hannover D 30625, Germany. 2 Department of Nephrology and Hypertension, Hannover Medical School, Hannover D 30625, Germany. 3 Integrated Research and Treatment Center Transplantation, Hannover Medical School, Hannover D 30625, Germany.
    [Show full text]
  • Gene Networks Activated by Specific Patterns of Action Potentials in Dorsal Root Ganglia Neurons Received: 10 August 2016 Philip R
    www.nature.com/scientificreports OPEN Gene networks activated by specific patterns of action potentials in dorsal root ganglia neurons Received: 10 August 2016 Philip R. Lee1,*, Jonathan E. Cohen1,*, Dumitru A. Iacobas2,3, Sanda Iacobas2 & Accepted: 23 January 2017 R. Douglas Fields1 Published: 03 March 2017 Gene regulatory networks underlie the long-term changes in cell specification, growth of synaptic connections, and adaptation that occur throughout neonatal and postnatal life. Here we show that the transcriptional response in neurons is exquisitely sensitive to the temporal nature of action potential firing patterns. Neurons were electrically stimulated with the same number of action potentials, but with different inter-burst intervals. We found that these subtle alterations in the timing of action potential firing differentially regulates hundreds of genes, across many functional categories, through the activation or repression of distinct transcriptional networks. Our results demonstrate that the transcriptional response in neurons to environmental stimuli, coded in the pattern of action potential firing, can be very sensitive to the temporal nature of action potential delivery rather than the intensity of stimulation or the total number of action potentials delivered. These data identify temporal kinetics of action potential firing as critical components regulating intracellular signalling pathways and gene expression in neurons to extracellular cues during early development and throughout life. Adaptation in the nervous system in response to external stimuli requires synthesis of new gene products in order to elicit long lasting changes in processes such as development, response to injury, learning, and memory1. Information in the environment is coded in the pattern of action-potential firing, therefore gene transcription must be regulated by the pattern of neuronal firing.
    [Show full text]
  • Combinatorial Interactions Between AP-1 and Ets Domain Proteins
    MOLECULAR AND CELLULAR BIOLOGY, Mar. 1994, p. 2129-2139 Vol. 14, No. 3 0270-7306/94/$04.00+0 Copyright C) 1994, American Society for Microbiology Combinatorial Interactions between AP-1 and ets Domain Proteins Contribute to the Developmental Regulation of the Macrophage Scavenger Receptor Gene HONG WU,1'2 KAREN MOULTON,3 ANDREW HORVAI,1'2 SHREYA PARIK,' AND CHRISTOPHER K. GLASS' 3* Divisions of Cellular and Molecular Medicine and Endocrinology and Metabolism,1 Biomedical Sciences Graduate Program,2 and Department of Medicine,3 University of California, San Diego, La Jolla, California 92093-0656 Received 30 September 1993/Returned for modification 23 November 1993/Accepted 17 December 1993 Macrophage development is regulated by a complex set of hormone-like molecules and cell adhesion events that control the growth and differentiation of progenitor cells. The macrophage scavenger receptor (SR) gene becomes markedly upregulated during the final stages of monocyte-to-macrophage differentiation and provides a model for the identification and characterization of transcription factors that control this process. In this report, we have identified three genomic regulatory elements that are required for transactivation of the SR gene in the THP-1 monocytic leukemia cell line following induction of macrophage differentiation by tetradecanoyl phorbol acetate. Each of these regulatory elements contains a near-consensus binding site for members of the AP-1 gene family, while the two most quantitatively important elements also contain juxtaposed binding sites for ets domain transcription factors. We demonstrate that tetradecanoyl phorbol acetate treatment results in a marked and prolonged increase in AP-1 binding activity on these elements, which can be accounted for almost entirely by c-jun andjunB.
    [Show full text]
  • In Vitro Targeting of Transcription Factors to Control the Cytokine Release Syndrome in 2 COVID-19 3
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.29.424728; this version posted December 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 In vitro Targeting of Transcription Factors to Control the Cytokine Release Syndrome in 2 COVID-19 3 4 Clarissa S. Santoso1, Zhaorong Li2, Jaice T. Rottenberg1, Xing Liu1, Vivian X. Shen1, Juan I. 5 Fuxman Bass1,2 6 7 1Department of Biology, Boston University, Boston, MA 02215, USA; 2Bioinformatics Program, 8 Boston University, Boston, MA 02215, USA 9 10 Corresponding author: 11 Juan I. Fuxman Bass 12 Boston University 13 5 Cummington Mall 14 Boston, MA 02215 15 Email: [email protected] 16 Phone: 617-353-2448 17 18 Classification: Biological Sciences 19 20 Keywords: COVID-19, cytokine release syndrome, cytokine storm, drug repurposing, 21 transcriptional regulators 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.12.29.424728; this version posted December 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 22 Abstract 23 Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing 24 hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators 25 of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription 26 factors (TFs) for therapeutic targeting using approved drugs.
    [Show full text]
  • Comprehensive Epigenome Characterization Reveals Diverse Transcriptional Regulation Across Human Vascular Endothelial Cells
    Nakato et al. Epigenetics & Chromatin (2019) 12:77 https://doi.org/10.1186/s13072-019-0319-0 Epigenetics & Chromatin RESEARCH Open Access Comprehensive epigenome characterization reveals diverse transcriptional regulation across human vascular endothelial cells Ryuichiro Nakato1,2† , Youichiro Wada2,3*†, Ryo Nakaki4, Genta Nagae2,4, Yuki Katou5, Shuichi Tsutsumi4, Natsu Nakajima1, Hiroshi Fukuhara6, Atsushi Iguchi7, Takahide Kohro8, Yasuharu Kanki2,3, Yutaka Saito2,9,10, Mika Kobayashi3, Akashi Izumi‑Taguchi3, Naoki Osato2,4, Kenji Tatsuno4, Asuka Kamio4, Yoko Hayashi‑Takanaka2,11, Hiromi Wada3,12, Shinzo Ohta12, Masanori Aikawa13, Hiroyuki Nakajima7, Masaki Nakamura6, Rebecca C. McGee14, Kyle W. Heppner14, Tatsuo Kawakatsu15, Michiru Genno15, Hiroshi Yanase15, Haruki Kume6, Takaaki Senbonmatsu16, Yukio Homma6, Shigeyuki Nishimura16, Toutai Mitsuyama2,9, Hiroyuki Aburatani2,4, Hiroshi Kimura2,11,17* and Katsuhiko Shirahige2,5* Abstract Background: Endothelial cells (ECs) make up the innermost layer throughout the entire vasculature. Their phe‑ notypes and physiological functions are initially regulated by developmental signals and extracellular stimuli. The underlying molecular mechanisms responsible for the diverse phenotypes of ECs from diferent organs are not well understood. Results: To characterize the transcriptomic and epigenomic landscape in the vascular system, we cataloged gene expression and active histone marks in nine types of human ECs (generating 148 genome‑wide datasets) and carried out a comprehensive analysis with chromatin interaction data. We developed a robust procedure for comparative epigenome analysis that circumvents variations at the level of the individual and technical noise derived from sample preparation under various conditions. Through this approach, we identifed 3765 EC‑specifc enhancers, some of which were associated with disease‑associated genetic variations.
    [Show full text]
  • Genome-Wide Analysis of the Zebrafish ETS Family Identifies Three Genes Required for Hemangioblast Differentiation Or Angiogenesis
    Genome-Wide Analysis of the Zebrafish ETS Family Identifies Three Genes Required for Hemangioblast Differentiation or Angiogenesis Feng Liu, Roger Patient Abstract—ETS domain transcription factors have been linked to hematopoiesis, vasculogenesis, and angiogenesis. However, their biological functions and the mechanisms of action, remain incompletely understood. Here, we have performed a systematic analysis of zebrafish ETS domain genes and identified 31 in the genome. Detailed gene expression profiling revealed that 12 of them are expressed in blood and endothelial precursors during embryonic development. Combined with a phylogenetic tree assay, this suggests that some of the coexpressed genes may have redundant or additive functions in these cells. Loss-of-function analysis of 3 of them, erg, fli1, and etsrp, demonstrated that erg and fli1 act cooperatively and are required for angiogenesis possibly via direct regulation of an endothelial cell junction molecule, VE-cadherin, whereas etsrp is essential for primitive myeloid/endothelial progenitors (hemangio- blasts) in zebrafish. Taken together, these results provide a global view of the ETS genes in the zebrafish genome during embryogenesis and provide new insights on the functions and biology of erg, fli1, and etsrp, which could be applicable to higher vertebrates, including mice and humans. (Circ Res. 2008;103:1147-1154.) Key Words: zebrafish Ⅲ gene duplication Ⅲ ETS transcription factors Ⅲ hemangioblast Ⅲ angiogenesis ebrafish has been recognized as an excellent genetic and during embryonic development and adulthood and have been Zdevelopmental biology model to study hematopoiesis linked with diverse biological processes, from hematopoiesis, and vessel development. Large numbers of genetic mutants vasculogenesis, and angiogenesis to neurogenesis. Many and transgenic lines in both blood and endothelial lineages important blood and endothelial regulators have well- have become available.
    [Show full text]
  • Deficits in Human Trisomy 21 Ipscs and Neurons
    Deficits in human trisomy 21 iPSCs and neurons Jason P. Weicka,1, Dustie L. Helda, George F. Bonadurer IIIa, Matthew E. Doersa, Yan Liua, Chelsie Maguirea, Aaron Clarka, Joshua A. Knackerta, Katharine Molinaroloa, Michael Mussera, Lin Yaoa, Yingnan Yina, Jianfeng Lua, Xiaoqing Zhanga, Su-Chun Zhanga,b,c,d, and Anita Bhattacharyyaa,2 aWaisman Center, bNeuroscience Training Program, and Departments of cNeuroscience and dNeurology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53705 Edited by Fred H. Gage, The Salk Institute for Biological Studies, San Diego, CA, and approved May 1, 2013 (received for review September 26, 2012) Down syndrome (trisomy 21) is the most common genetic cause of uniparental disomy (or isodisomy), which is often associated with intellectual disability, but the precise molecular mechanisms un- trisomy rescue (Fig. 1D). Short tandem repeats at various loci derlying impaired cognition remain unclear. Elucidation of these indicated that the Ts21 and euploid lines were isogenic other than mechanisms has been hindered by the lack of a model system that the presence of Ts21 (Fig. 1E). To increase statistical power, contains full trisomy of chromosome 21 (Ts21) in a human genome fibroblasts from a second DS individual were reprogrammed us- that enables normal gene regulation. To overcome this limitation, we ing Sendai virus (12), an RNA virus, which yielded another Ts21 created Ts21-induced pluripotent stem cells (iPSCs) from two sets of iPSC line (Fig. 1C). All iPSC clones were named according to Ts21 human fibroblasts. One of the fibroblast lines had low level standardized naming procedures (Fig. 1F) (13) and used in all mosaicism for Ts21 and yielded Ts21 iPSCs and an isogenic control experiments.
    [Show full text]